Skip to main content

Table 1 Sequential change of CP amounts attached to inside of stocked vials

From: Prevention of the exposure by cyclophosphamide oral tablet

   

Stored periods

   

Day 7

Day 14

Day 28

Day 56

Amount of CPa

(ng/vial)

Vehicle

RTb

ND

ND

ND

ND

4 °C

ND

ND

ND

ND

Endoxan® tablets

RT

8.0 ± 1.2

10.3 ± 2.7

17.2 ± 2.0*

49.0 ± 6.7**

4 °C

ND

<3

<3

6.0 ± 1.0##

  1. a) cyclophosphamide
  2. b) room temperature
  3. Data are represented by mean ± SD. * p < 0.05; ** p < 0.01, Dunnet’s multiple comparison test; ## p < 0.01, unpaired t-test; ND; not detected, < 3; under the detection limit (3 ng/vial)